Number of patients | 39 |
Number of procedures | 44 |
Number of treated arteries | 49 |
Patients’ demographics |  |
Median age (years ± standard deviation) | 69.7 ± 9.8 |
Gender (n, %) | Â |
 Male | 21 (54%) |
 Female | 18 (46%) |
BMI (kg/m2 ± standard deviation) | 19.3 ± 10.3 |
History of (n, %) | Â |
 Hypertension | 38 (97%) |
 Heavy smoking [> 20 pack years] | 27 (69%) |
 Diabetes | 21 (53%) |
 Coronary artery disease ± coronary bypass surgery | 27 (69%) |
 Stroke | 2 (5%) |
 Peripheral artery disease | 28 (72%) |
 Chronic kidney disease stage 1 (GFR > 90 mL/min/1.73m2) | 7 (18%) |
 Chronic kidney disease stage 2 (GFR 60–89 mL/min/1.73m2) | 13 (33%) |
 Chronic kidney disease stage 3 (GFR 30–59 mL/min/1.73m2) | 12 (31%) |
 Chronic kidney disease stage 4 + 5 (GFR < 29 mL/min/1.73m2 or dialysis) | 7 (18%) |
 Anemia (hemoglobin < 13.5 g/dl; hematocrit < 40%) | 30 (77%) |
Clinical characteristics | Â |
Clinical symptoms at presentation (n, %) | Â |
 Abdominal pain (postprandial) | 39 (100%) |
 Weight loss | 36 (92%) |
 Ischemic gastritis/colitis ± bleeding | 15 (38%) |
Immediate post-interventional pain decrease per procedure (n, %) | 42 (95%) |
Number of patients lost to follow-up after discharge (n, %) | 11 (28%) |
Weight gain per patient in follow-up (n, %) | 21 (75%) |
Recurrence of symptoms per patient in follow-up (n, %) | 12 (43%) |
Number of recorded deaths in follow-up (n, %) | 7 (25%) |
Bowel-infarction-related death in follow-up (n, %) | 4 (14%) |